199 related articles for article (PubMed ID: 13335855)
21. Hypoglycaemic sulphonamides in treatment of diabetes.
WALKER G; LEESE WL; NABARRO JD
Br Med J; 1956 Aug; 2(4990):451-2. PubMed ID: 13342511
[No Abstract] [Full Text] [Related]
22. Clinical trial of the new oral hypoglycaemic agent BZ 55.
HUNT JA; OAKLEY W; LAWRENCE RD
Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509
[No Abstract] [Full Text] [Related]
23. Trial of an oral hypoglycaemic agent in diabetes.
WOLFF FW; STEWART GA; CROWLEY MF; BLOOM A
Br Med J; 1956 Aug; 2(4990):440-5. PubMed ID: 13342508
[No Abstract] [Full Text] [Related]
24. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan].
FRAENKEL KA; SCHULZ K
Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175
[No Abstract] [Full Text] [Related]
25. Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report.
RIDOLFO AS; KIRTLEY WR
J Am Med Assoc; 1956 Apr; 160(15):1285-8. PubMed ID: 13306540
[No Abstract] [Full Text] [Related]
26. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
DIENGOTT D; DOLGER H; MIRSKY IA
Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
[No Abstract] [Full Text] [Related]
27. Recent studies relative to the treatment of diabetes; special reference to new oral antidiabetic drugs.
WILLIAMS RH; HENLEY ED
AMA Arch Intern Med; 1957 Apr; 99(4):501-18. PubMed ID: 13410156
[No Abstract] [Full Text] [Related]
28. [Oral treatment of diabetes mellitus with D-860, a new hypoglycemic but not sulfonamidic drug; clinical study of 90 cases].
INTROZZI P; MARIGO S
Prog Med (Napoli); 1956 Sep; 12(17):513-27. PubMed ID: 13379550
[No Abstract] [Full Text] [Related]
29. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
[No Abstract] [Full Text] [Related]
30. [A brief contribution on cutaneous side effects of the oral antidiabetic remedy BZ 55 (nadisan)].
WALTHER H; WALZ H
Ther Ggw; 1956 May; 95(5):183-4. PubMed ID: 13352317
[No Abstract] [Full Text] [Related]
31. [Anti-diabetic sulfamide therapy; personal experience].
PAVEL I; PIRVULESCU M; GARTENBERG A
Med Interna (Bucur); 1957 Mar; 9(3):384-94. PubMed ID: 13450863
[No Abstract] [Full Text] [Related]
32. [Sulfamides, hypoglycaemic and antidiabetic].
Thomas J
Rev Prat; 1956 May; 6(14):1548-54. PubMed ID: 13336923
[No Abstract] [Full Text] [Related]
33. CURRENT investigation of the hypoglycemic action of sulfonylureas.
Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
[No Abstract] [Full Text] [Related]
34. Hypoglycaemic sulphonamides in the management of diabetes mellitus.
DOWNIE E; BORNSTEIN J; HUDSON B
Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634
[No Abstract] [Full Text] [Related]
35. Clinical studies on the hypoglycaemic action of the sulphonylureas.
BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
[No Abstract] [Full Text] [Related]
36. [Oral therapy of diabetes mellitus with invenol].
BLOCH J; LENHARDT A
Wien Med Wochenschr; 1956 Jul; 106(27):594-8. PubMed ID: 13353170
[No Abstract] [Full Text] [Related]
37. [Trial therapy of diabetes mellitus with BZ 55].
BOULIN R
Presse Med (1893); 1956 Apr; 64(28):643-5. PubMed ID: 13335854
[No Abstract] [Full Text] [Related]
38. The role of sulphonylurea derivatives in the management of diabetes mellitus; a preliminary report.
DOWNIE E; BORNSTEIN J; HUDSON B; TAYLOR K
Med J Aust; 1956 Jun; 43(26):1072-8. PubMed ID: 13347438
[No Abstract] [Full Text] [Related]
39. Treatment of diabetes mellitus with BZ-55.
METZLER WS
Can Med Assoc J; 1956 Jun; 74(12):987-8. PubMed ID: 13329952
[No Abstract] [Full Text] [Related]
40. Treatment of diabetes mellitus with BZ-55.
CHARLES B
Can Med Assoc J; 1956 Jun; 74(12):985-7. PubMed ID: 13329951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
